Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease.

about

Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease.

Item

http://www.wikidata.org/entity/Q55054211

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Proteomic characterization of ...... alcoholic fatty liver disease.

@en

Proteomic characterization of ...... alcoholic fatty liver disease.

@nl

type

Item

label

Proteomic characterization of ...... alcoholic fatty liver disease.

@en

Proteomic characterization of ...... alcoholic fatty liver disease.

@nl

prefLabel

Proteomic characterization of ...... alcoholic fatty liver disease.

@en

Proteomic characterization of ...... alcoholic fatty liver disease.

@nl

P1476

Proteomic characterization of ...... alcoholic fatty liver disease.

@en

P2093

Anand Rohatgi

http://www.w3.org/2001/XMLSchema#string

Avinash Y L Jadhav

http://www.w3.org/2001/XMLSchema#string

Eugene Drigalenko

http://www.w3.org/2001/XMLSchema#string

Kate Merath

http://www.w3.org/2001/XMLSchema#string

Mark A Sarzynski

http://www.w3.org/2001/XMLSchema#string

Matthew I Goldblatt

http://www.w3.org/2001/XMLSchema#string

Michael Olivier

http://www.w3.org/2001/XMLSchema#string

Prahlad K Rao

http://www.w3.org/2001/XMLSchema#string

Richard A Komorowski

http://www.w3.org/2001/XMLSchema#string

Samer Gawrieh

http://www.w3.org/2001/XMLSchema#string

P2860

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

2016 update of the PRIDE database and its related tools

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Andromeda: a peptide search engine integrated into the MaxQuant environment

The Perseus computational platform for comprehensive analysis of (prote)omics data.

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

Improved method for the analysis of membrane proteins by mass spectrometry

Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile.

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

P2888

s12014-018-9186-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12014-018-9186-0

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101360595

http://www.w3.org/2001/XMLSchema#string

P698

29527140

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

P932

5839024

http://www.w3.org/2001/XMLSchema#string